OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Allergy and Clinical Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
The use of environmental exposure chambers in studies related to ocular surface effects	57
What molecular allergy teaches us about genetics and epidemiology of allergies	28
The pathogenetic role of Th17 immune response in atopic dermatitis	26
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	23
Pulmonary function testing for the diagnosis of asthma in preschool children	21
Consequences of severe asthma exacerbations	21
E-cigarettes and asthma in adolescents	20
Is immunotherapy safe for treatment of severe asthma	19
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	17
Cow's milk allergy	17
Economic burden of drug-induced anaphylaxis: what can we do better?	17
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	17
New approaches in childhood asthma treatment	16
Anaphylaxis due to antiallergic and antiasthmatic biologics	16
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	16
Liver disease in primary antibody deficiencies	16
Atopic manifestations of inborn errors of immunity	16
Real-world evidence of allergen immunotherapy	15
Update on occupational allergy, including asthma, to soluble platinum salts	15
Mast cell conditions and drug allergy: when to suspect and how to manage	14
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	13
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	13
Editorial introductions	13
Editorial introductions	13
Transition of care in inborn errors of immunity	13

Ocular involvement in allergic drug reactions	13
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	12
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	12
Perioperative anaphylaxis: when the allergological work-up goes negative	12
Drug allergy desensitization is not a unique recipe	12
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	12
Editorial introductions	12
Updates in diagnosis and management of paediatric mastocytosis	11
A review of food allergy-related costs with consideration to clinical and demographic factors	11
Management and treatment of perioperative hypersensitivity	11
Editorial introductions	11
Atopic dermatitis endotypes: knowledge for personalized medicine	10
Updates in school-based asthma management	10
Occupational causes of chronic obstructive pulmonary disease: an update	10
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	10
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	10
Health disparities in allergic diseases	10
Role of the ocular surface microbiome in allergic eye diseases	9
Editorial introductions	9
Clinical remission in severe asthma: lights and shadows on an ambitious goal	9
Biomarkers in the diagnosis of mast cell activation	9
The complexity in DNA methylation analysis of allergic diseases	9
Food-labeling issues for severe food-allergic consumers	9
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	9
Current strategies for phenotyping and managing asthma in preschool children	8
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	8
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	8
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	8
Strengthening the case for intralymphatic immunotherapy	8
Food allergy: new therapeutic options open deeper questions	8
Precision medicine to personalize medicine in allergic airway disease	7
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	7
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	7
Adverse effects of anti-cancer biologics on the ocular surface	7
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	7
Precision allergy molecular diagnosis applications in food allergy	7
Interstitial lung diseases in inborn errors of immunity	7
New causes of occupational allergic contact dermatitis	7
Occupational respiratory allergy to reactive dyes	7
Immunobiologicals and ocular surface disease	7
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	7
The role of macrolides in chronic rhinosinusitis and nasal polyps	7
Giant cell arteritis and innovative treatments	7
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	7
New insights into the diagnosis and management of Stevens–Johnson syndrome and toxic epidermal necrolysis	6
Editorial introductions	6
Editorial introductions	6
MicroCrystalline Tyrosine-adsorbed immunotherapy	6
How E-cigarettes and vaping can affect asthma in children and adolescents	6
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	6

Type-2-low severe asthma endotypes for new treatments: the new asthma frontier	6
Clinical outcomes of AIT in the elderly population	6
Endotypes of occupational asthma	6
Role of biologics in severe food allergy	6
Neurostimulation for dry eye disease	6
The risk of anaphylaxis on holidays	6
Omalizumab is the Columbus egg for food allergies	6
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	6
New evidence in food allergies treatment	6
The development of the DEFASE project	6
Ocular surface disorders: office procedures for the allergist/clinical immunologist	6
Editorial: Pharmacotherapy and evidence based medicine	5
New insights into the mechanisms of aspirin-exacerbated respiratory disease	5
Editorial introductions	5
Perioperative anaphylaxis: updates on pathophysiology	5
Global patterns of drug allergy-induced fatalities: a wake-up call to prevent avoidable deaths	5
Diagnosis, management and therapeutic options for eosinophilic esophagitis	5
Editorial introductions	5
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	5
An update on patient reported outcomes in type 2 inflammation airway disease	5
Editorial introductions	5
Recent advances in the diagnosis and management of tree nut and seed allergy	5
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	5
Moderate asthma: burden, mechanisms and therapeutic perspectives	5
Update on aspirin exacerbated respiratory disease with chronic rhinosinusitis	5
Genetic landscape of atopic dermatitis	5
Editorial introductions	5
Anaphylaxis in elderly people	5
Integrative therapeutics for ocular surface disorders	4
Perspectives in precautionary allergen labelling of prepackaged foods after the FAO/WHO consultation	4
Long-term outcome of occupational asthma with different etiology	4
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	4
Grading the severity of anaphylaxis	4
Advances in gene therapy for inborn errors of immunity	4
Anaphylaxis: glimpse into the future, attention to the present	4
The evolution of cyclosporine treatments for treatment of ocular surface diseases	4
Editorial introductions	4
Corneal complications of rheumatoid arthritis	4
Chronic urticaria: not only after COVID-19 vaccination	4
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	4
Editorial introductions	4
Regulatory T-cells in asthma	4
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis	4
STAT1 and STAT3 gain of function: clinically heterogenous immune regulatory disorders	4
Biologics to treat anaphylaxis	4
Applying the new guidelines to asthma management in children	4
Biologicals in IgE-mediated food allergy	4
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	4
Clinical outcomes of efficacy in food allergen immunotherapy trials	4
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children	4
Inborn errors of immunity underlying defective T-cell memory	4
Perspectives in the validation of DEFASE: a paradigm shift in food allergy management	4
Predicting the course of asthma from childhood until early adulthood	4
Management of food allergy based on oral food challenge	4
Biologics and severe asthma in children	4